trachoma
Information
- Disease name
- trachoma
- Disease ID
- DOID:11265
- Description
- "A commensal bacterial infectious disease that results_in infection located_in eye, has_material_basis_in Chlamydia trachomatis (A, B, Ba and C serovars), which is transmitted_by contact with eye discharge from the infected person and transmitted_by congenital method. The infection causes eyelid to turn inward which makes eyelashes to scratch the cornea." [url:http\://en.wikipedia.org/wiki/Trachoma, url:http\://www.cdc.gov/ncidod/dbmd/diseaseinfo/trachoma_t.htm, url:http\://www.who.int/blindness/causes/priority/en/index2.html]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03570814 | Completed | Phase 4 | Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin | December 1, 2021 | February 1, 2022 |
| NCT00221364 | Completed | Phase 4 | Trachoma Elimination Follow-up | March 2003 | April 2005 |
| NCT00322972 | Completed | Phase 4 | Trachoma Amelioration in Northern Amhara (TANA) | June 2006 | May 2014 |
| NCT00347607 | Completed | Phase 4 | Study of Three Alternatives for Mass Treatment in Trachoma Villages of Tanzania | April 2002 | November 2005 |
| NCT00347763 | Completed | Phase 4 | Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania | June 2000 | October 2002 |
| NCT00348478 | Completed | Phase 4 | Impact of Water and Health Education Programs on Trachoma and Ocular C. Trachomatis in Niger | December 2005 | January 2008 |
| NCT00356720 | Completed | Phase 3 | Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma | January 2004 | May 2004 |
| NCT00522860 | Completed | Phase 4 | A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery | March 2008 | May 2010 |
| NCT00618449 | Completed | Phase 4 | Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger | January 2008 | August 2009 |
| NCT00792922 | Completed | Phase 4 | Partnership for Rapid Elimination of Trachoma | May 2008 | June 2014 |
| NCT00886015 | Completed | N/A | Modified Instrumentation for Surgery to Correct Trichiasis | May 2009 | June 2012 |
| NCT01202331 | Completed | Phase 4 | Tripartite International Research for the Elimination of Trachoma | November 2010 | May 2014 |
| NCT01767506 | Completed | N/A | A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial | January 2013 | February 2016 |
| NCT05634759 | Completed | Phase 4 | Enhancing the A in SAFE for Trachoma | May 4, 2022 | August 5, 2023 |
| NCT01949454 | Completed | N/A | Fluorometholone as Ancillary Therapy for TT Surgery | November 2013 | April 2016 |
| NCT03926728 | Completed | Phase 1 | Safety and Immunogenicity of a Chlamydia Vaccine CTH522 | February 17, 2020 | February 22, 2022 |
| NCT02373657 | Completed | N/A | Water Uptake for Health in Amhara Pilot | April 2014 | May 2017 |
| NCT03813069 | Completed | Phase 2 | Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma | January 10, 2019 | December 23, 2019 |
| NCT03676140 | Completed | Phase 3 | Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) | October 1, 2018 | January 1, 2019 |
| NCT06289647 | Not yet recruiting | Phase 4 | Azithromycin Reduction to Reach Elimination of Trachoma B | July 28, 2024 | August 31, 2029 |
| NCT03335072 | Recruiting | Phase 4 | Kebele Elimination of Trachoma for Ocular Health | February 7, 2022 | March 1, 2028 |
| NCT02754583 | Recruiting | Phase 3 | Sanitation, Water, and Instruction in Face-washing for Trachoma I/II | December 5, 2015 | August 31, 2025 |
| NCT04185402 | Recruiting | Phase 4 | Azithromycin Reduction to Reach Elimination of Trachoma | May 29, 2021 | October 31, 2026 |
| NCT03523156 | Suspended | Phase 4 | Trachoma Elimination Study by Focused Antibiotic (TESFA) | April 2024 | April 2026 |
| NCT03997487 | Terminated | N/A | Smartphone App for Taking Images of Conjunctivae | July 8, 2019 | July 12, 2019 |
| NCT04002726 | Terminated | N/A | App-based Versus Slide-based Inter-grader Agreement (IGA) Test for Trachoma Graders | July 8, 2019 | July 12, 2019 |
| NCT00286026 | Withdrawn | Phase 4 | Azithromycin in Control of Trachoma II | June 2005 | August 2009 |
| NCT02655432 | Withdrawn | Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population | January 2016 | June 2016 | |
| NCT01903057 | Withdrawn | Phase 4 | Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis | February 2014 | July 2014 |
| NCT02176057 | Withdrawn | Phase 2/Phase 3 | Nepal Elimination of Trachoma Study | August 2014 |
- Exact Synonym (Disease Ontology)
- active stage trachoma
- Exact Synonym (Disease Ontology)
- trachoma dubium
- Disase is a (Disease Ontology)
- DOID:0050339
- Cross Reference ID (Disease Ontology)
- GARD:10374
- Cross Reference ID (Disease Ontology)
- ICD10CM:A71
- Cross Reference ID (Disease Ontology)
- ICD10CM:A71.0
- Cross Reference ID (Disease Ontology)
- ICD10CM:A71.1
- Cross Reference ID (Disease Ontology)
- ICD9CM:076
- Cross Reference ID (Disease Ontology)
- ICD9CM:076.0
- Cross Reference ID (Disease Ontology)
- ICD9CM:076.1
- Cross Reference ID (Disease Ontology)
- MESH:D014141
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154367007
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:29976007
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:52812002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0040592
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153107
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153108
- ICD10 class code (Insert disease from ICD10)
- A71
- ICD10 preferred id (Insert disease from ICD10)
- D0000357
- MeSH unique ID (MeSH (Medical Subject Headings))
- D014141